BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26395856)

  • 1. [Exenteration of the Orbit for Basal Cell Carcinoma].
    Furdová A; Horkovičová K; Krčová I; Krásnik V
    Cesk Slov Oftalmol; 2015 Aug; 71(4):209-16. PubMed ID: 26395856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtotal Exenteration of the Orbit for Benign Orbital Disease.
    Furdova A; Babal P; Zahorjanova P; Sekac J
    J Craniofac Surg; 2020; 31(5):1367-1369. PubMed ID: 32224777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Malignant Choroidal Melanoma in T4 Orbital Stage; Prosthesis of the Orbit].
    Furdová A; Ferková A; Krásnik V; Krčová I; Horkovičová K
    Cesk Slov Oftalmol; 2015 Jun; 71(3):150-7. PubMed ID: 26201361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Non-melanotic Tumors of the Eyelids Skin and Inner Corner - Basocellular Carcinoma].
    Furdová A; Horkovičová K; Babál P; Kobzová D; Ondrušová M
    Cesk Slov Oftalmol; 2015; 71(6):293-301. PubMed ID: 26782918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Orbital exenteration. A preventable course in tumor treatment?!].
    Schayan-Araghi K; Press UP; Hübner H
    Ophthalmologe; 1994 Aug; 91(4):536-9. PubMed ID: 7950131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for orbital exenteration in periocular Basal cell carcinoma.
    Iuliano A; Strianese D; Uccello G; Diplomatico A; Tebaldi S; Bonavolontà G
    Am J Ophthalmol; 2012 Feb; 153(2):238-241.e1. PubMed ID: 21982108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Metastatic Eyelid Carcinoma.
    Bonavolontà P; Dell'Aversana Orabona G; Abbate V; Iaconetta G; Bonavolontà G; Califano L
    J Craniofac Surg; 2017 Nov; 28(8):e722-e725. PubMed ID: 28885435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience with eyelid-sparing orbital exenteration: the 2000 Tullos O. Coston Lecture.
    Shields JA; Shields CL; Demirci H; Honavar SG; Singh AD
    Ophthalmic Plast Reconstr Surg; 2001 Sep; 17(5):355-61. PubMed ID: 11642492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Food and Drug Administration Approval of Vismodegib on Prevalence of Orbital Exenteration as a Necessary Surgical Treatment for Locally Advanced Periocular Basal Cell Carcinoma.
    Sagiv O; Ding S; Ferrarotto R; Glisson B; Altan M; Johnson F; Elamin Y; Thakar SD; Nagarajan P; Esmaeli B
    Ophthalmic Plast Reconstr Surg; 2019; 35(4):350-353. PubMed ID: 30365473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supraestructure maxillectomy and orbital exenteration for treatment of basal cell carcinoma of inferior eyelid: case report and review.
    Sebastián Villalón-López J; Arturo Valle-Mejía C; Patiño-Lara A; Moreno-Pérez Bertha A; Alejo Muñoz-López J; Alcantar-Andrade A
    J Cancer Res Ther; 2005; 1(3):132-5. PubMed ID: 17998643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orbital exenteration: a 10-year experience of a general oncology hospital.
    Soysal HG
    Orbit; 2010 Jun; 29(3):135-9. PubMed ID: 20497078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orbital exenteration: a 13 year Manchester experience.
    Rahman I; Cook AE; Leatherbarrow B
    Br J Ophthalmol; 2005 Oct; 89(10):1335-40. PubMed ID: 16170127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supraestructure maxillectomy and orbital exenteration for treatment of basal cell carcinoma of inferior eyelid: case report and review.
    Villalon-Lopez JS; Valle-Mejia CA; Patino-Lara A; Moreno-Perez BA; Munoz-Lopez JA; Alcantar-Andrade A
    J Cancer Res Ther; 2006; 2(3):140-3. PubMed ID: 17998694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orbital exenteration for invasive skin tumours.
    Tyers AG
    Eye (Lond); 2006 Oct; 20(10):1165-70. PubMed ID: 17019414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RECURRENT PERIOCULAR BASAL CELL CARCINOMA. CASE REPORT.
    Prídavková Z; Bieliková A; Ferková N; Lysková D
    Cesk Slov Oftalmol; 2021; 77(4):208-213. PubMed ID: 34507497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orbital exenteration in periorbital malignancies.
    Roche P; Timon C
    Surgeon; 2012 Aug; 10(4):189-93. PubMed ID: 22818275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality following exenteration for malignant tumours of the orbit.
    Rahman I; Maino A; Cook AE; Leatherbarrow B
    Br J Ophthalmol; 2005 Nov; 89(11):1445-8. PubMed ID: 16234450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orbital exenteration for secondary orbital tumors: a series of seven cases.
    Lin HF; Lui CC; Hsu HC; Lin SA
    Chang Gung Med J; 2002 Sep; 25(9):599-605. PubMed ID: 12479621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periocular Basal Cell Carcinoma Predictors for Recurrence and Infiltration of the Orbit.
    Furdova A; Lukacko P
    J Craniofac Surg; 2017 Jan; 28(1):e84-e87. PubMed ID: 27906855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use of latex biomembrane in exenteration: case report].
    Fugimoto F; Jervásio AC; Misawa AK; Garcia R; Matayoshi S
    Arq Bras Oftalmol; 2007; 70(5):854-7. PubMed ID: 18157314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.